Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bioatla Inc (NQ: BCAB )

3.370 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,793
Open 3.370
Bid (Size) 3.170 (3)
Ask (Size) 3.260 (2)
Prev. Close 3.370
Today's Range 3.370 - 3.370
52wk Range 1.240 - 4.020
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BCAB Stock Earnings: BioAtla Beats EPS for Q4 2023
BCAB stock results show that BioAtla beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
BioAtla: Q4 Earnings Insights
Via Benzinga

Performance

YTD
+27.17%
+27.17%
1 Month
-0.59%
-0.59%
3 Month
+75.98%
+75.98%
6 Month
+121.71%
+121.71%
1 Year
-5.60%
-5.60%

More News

Read More
Earnings Scheduled For March 26, 2024
Via Benzinga
Preview: BioAtla's Earnings
Via Benzinga
Analyst Ratings for BioAtla
Via Benzinga
The Latest Analyst Ratings for BioAtla
Via Benzinga
Where BioAtla Stands With Analysts
Via Benzinga
Around $2M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Topics Stocks
Exposures US Equities
BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
From BioAtla, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
BioAtla Presented Phase 2 Clinical Trial Data at the IASLC 2023 North America Conference on Lung Cancer and Virtual KOL Event
From BioAtla, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
BioAtla to Participate in the JMP Securities Hematology and Oncology Summit
From BioAtla, Inc.
Via GlobeNewswire
BioAtla to Host Virtual KOL Event to Review IASLC Data on BA3011 in NSCLC
From BioAtla, Inc.
Via GlobeNewswire
BioAtla Reports Third Quarter 2023 Financial Results and Highlights Recent Progress
From BioAtla, Inc.
Via GlobeNewswire
BioAtla to Participate in the Jefferies London Healthcare Conference
From BioAtla, Inc.
Via GlobeNewswire
BioAtla’s Jay M. Short, Ph.D., Selected for The Explorers Club Lowell Thomas Award
From BioAtla, Inc.
Via GlobeNewswire
BioAtla Provides Guidance on Near-Term Milestones and Plans to Announce Third Quarter 2023 Financial Results and Business Update on November 7, 2023
From BioAtla, Inc.
Via GlobeNewswire
BioAtla to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
From BioAtla, Inc.
Via GlobeNewswire
BioAtla to Participate in Upcoming Investor Conferences in August
From BioAtla, Inc.
Via GlobeNewswire
BioAtla Reports Second Quarter 2023 Financial Results and Highlights Recent Progress
From BioAtla, Inc.
Via GlobeNewswire
BioAtla to Announce Second Quarter 2023 Financial Results and Provide Business Highlights on August 1, 2023
From BioAtla, Inc.
Via GlobeNewswire
BioAtla Added to Membership of U.S. Small-Cap Russell 2000® Index
From BioAtla, Inc.
Via GlobeNewswire
BioAtla to Participate in the Jefferies Healthcare Conference
From BioAtla, Inc.
Via GlobeNewswire
BioAtla Reports First Quarter 2023 Financial Results and Highlights Recent Progress
From BioAtla, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.